The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s testosterone replacement therapy market report forecasts the testosterone replacement therapy market size to grow to $2.22 Billion by 2027, with a CAGR (compound annual growth rate) of more than 4%.

Learn More On The Testosterone Replacement Therapy Market Report 2023 – https://www.thebusinessresearchcompany.com/report/testosterone-replacement-therapy-global-market-report

Testosterone Replacement Therapy Market Size Forecast
The global testosterone replacement therapy market is expected to grow from $1.75 billion in 2022 to $1.85 billion in 2023 at a compound annual growth rate (CAGR) of 5.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global testosterone replacement therapy market size is expected to reach $2.22 billion in 2027 at a CAGR of 4.6%.

North America held the largest testosterone replacement therapy market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Testosterone Replacement Therapy Market Driver ­– Rise In The Testosterone Deficiency
According to the Western Michigan Urological Association’s report in 2022, a US-based urological association, around 13 million men in the United States suffer with low testosterone levels, which represents one in every four guys over the age of 30. As a result, the surge in testosterone deficiency is propelling the testosterone replacement therapy industry forward.

Request for A Sample Of The Global Testosterone Replacement Therapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9235&type=smp

Key Testosterone Replacement Therapy Market Trend – Product Innovation
To boost their market position, major testosterone replacement therapy businesses are producing unique medicines. Acesis BioMed, a biomedical business based in the United States, for example, developed ACE-167, a non-steroidal oral peptide treatment to treat low testosterone and hypogonadism, in December 2021. In contrast to anabolic steroids, which have major side effects and a high potential for abuse as performance-enhancing medications in testosterone treatment, ACE-167 is a peptide therapy that directs the body’s cells to naturally produce testosterone.

Testosterone Replacement Therapy Market Segment
1) By Product Type: Oral, Implants, Gel Or Creams, Patches, Buccal Adhesive, Parenteral, Other Products
2) By Indication: Hypogonadism, Autoimmune Conditions, Genetic Disorders, Sex Organ Surgeries, Other Indications
3) By Active Ingredient Type: Testosterone, Methyl Testosterone, Testosterone Undecanoate, Testosterone Enanthate, Testosterone Cypionate
4) By End User: Hospitals, Clinics, Other End-User

Testosterone Replacement Therapy Market Major Players and Strategies
Major players in the testosterone replacement therapy market are AbbVie Inc., Acerus Pharmaceuticals Corporation, Antares Pharma Inc., Bayer AG, BioTE Medical LLC, Clarus Therapeutics, Eli Lilly and Company, Endo Pharmaceuticals, Pfizer Inc., Teva Pharmaceutical Industries, Acrux Limited, Actiza Pharmaceutical, Aytu BioPharma, Cipla Limited, Sun Pharmaceutical Industries Limited, The Simple Pharma Company UK Limited, and Ferring Pharmaceuticals.

Tolmar Pharmaceuticals Inc., a US-based pharmaceutical business specialising in testosterone therapy, paid an unknown sum for Clarus Therapeutics Inc in October 2022. Tolmar Pharmaceuticals Inc. hopes to expand its urology and men’s health portfolio with the addition of JATENZO, a testosterone replacement medicine from Clarus Therapeutics, Inc. Clarus Therapeutics, Inc is a testosterone replacement treatment firm established in the United States.

The Testosterone Replacement Therapy Global Market Report 2023 covers regional data on testosterone replacement therapy market size, testosterone replacement therapy market trends and drivers, opportunities, strategies, and testosterone replacement therapy market competitor analysis. The countries covered in the testosterone replacement therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Testosterone replacement treatment (TRT) is a type of hormone therapy used to address low testosterone (T) levels in men, which can arise as a result of ageing or a medical condition.

View More Reports Related To The Testosterone Replacement Therapy Market –
Drugs For Hormonal Replacement Therapy Global Market Report 2023
Drugs For Immunotherapy Global Market Report 2023
Nucleic Acid Based Gene Therapy Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: